Expression of ALDH1A1 and CD44 in primary head and neck squamous cell carcinoma and their value for carcinogenesis, tumor progression and cancer stem cell identification

Leinung,Martin; Ernst,Benjamin; Döring,Constanze; Wagenblast,Jens; Tahtali,Aykut; Diensthuber,Marc; Stöver,Timo; Geissler,Christin

doi:10.3892/ol.2015.3542

Expression of ALDH1A1 and CD44 in primary head and neck squamous cell carcinoma and their value for carcinogenesis, tumor progression and cancer stem cell identification

Authors:
- Martin Leinung
- Benjamin Ernst
- Constanze Döring
- Jens Wagenblast
- Aykut Tahtali
- Marc Diensthuber
- Timo Stöver
- Christin Geissler
View Affiliations

Affiliations: Department of Otolaryngology, University Hospital Frankfurt, Frankfurt am Main 60590, Germany, Institute of Pathology, University Hospital Frankfurt, Frankfurt am Main 60590, Germany
Published online on: July 29, 2015 https://doi.org/10.3892/ol.2015.3542
Pages: 2289-2294

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In head and neck squamous cell carcinoma (HNSCC), aldehyde dehydrogenase 1 family, member A1 (ALDH1A1) and hyaluronan receptor cluster of differentiation 44 (CD44) are often used as cancer stem cell (CSC) markers. The aim of the present study was to examine the relevance of these proteins for HNSCC in general and for the identification of CSCs. Tumors from 48 patients with primary HNSCC were analyzed for the expression of ALDH1A1 and CD44. Additionally, the association of the proteins with the proliferation rate and epidermal growth factor receptor (EGFR) expression was analyzed. ALDH1A1 was expressed in 54.2% of the carcinoma samples while CD44 was expressed in 89.6% of the carcinoma samples. Most notably, these proteins were often not expressed exclusively in a subpopulation, but also in the majority of tumor cells (ALDH1A1: 30.8% of ALDH1A1+ tumors; CD44: 65.1% of CD44+ tumors). Furthermore, patients with ALDH1A1+ tumors exhibited worse survival rates. CD44 and EGFR expression patterns were overlapping within the tumors and the expression rates were significantly connected. Ki‑67+ tumor cells often expressed CD44. ALDH1A1 and CD44 expression patterns only partly overlapped. Consequently, ALDH1A1 and CD44 play significant roles in carcinogenesis and tumor progression. Within the present study, CD44 appeared to interact with EGFR and was more often expressed in primary HNSCC than the marker ALDH1A1. However, ALDH1A1 was a better marker to define a subpopulation of tumor cells. Finally, neither ALDH1A1 nor CD44, alone or combined, were sufficient to determine the CSC population in HNSCC.

View Figures

View References

1	Leemans CR, Braakhuis BJ and Brakenhoff RH: The molecular biology of head and neck cancer. Nat Rev Cancer. 11:9–22. 2011. View Article : Google Scholar : PubMed/NCBI
2	Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: GLOBOCAN 2012, cancer incidence and mortality worldwide: IARC cancerbase No. 11 [Internet]. Lyon, France: IARC; 1.0. 2013
3	Wu MJ, Jan CI, Tsay YG, Yu YH, Huang CY, Lin SC, Liu CJ, Chen YS, Lo JF and Yu CC: Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling. Mol Cancer. 9:2832010. View Article : Google Scholar : PubMed/NCBI
4	Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, Chen DT, Tai LK, Yung MC, Chang SC, et al: Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun. 385:307–313. 2009. View Article : Google Scholar : PubMed/NCBI
5	Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, Wicha MS and Prince ME: Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck. 32:1195–1201. 2010. View Article : Google Scholar : PubMed/NCBI
6	Visus C, Ito D, Amoscato A, MaciejewskaFranczak M, Abdelsalem A, Dhir R, Shin DM, Donnenberg VS, Whiteside TL and DeLeo AB: Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res. 67:10538–10545. 2007. View Article : Google Scholar : PubMed/NCBI
7	Ma I and Allan AL: The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev. 7:292–306. 2011. View Article : Google Scholar : PubMed/NCBI
8	Singh S, Brocker C, Koppaka V, Chen Y, Jackson BC, Matsumoto A, Thompson DC and Vasiliou V: Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress. Free Radic Biol Med. 56:89–101. 2013. View Article : Google Scholar : PubMed/NCBI
9	Turley EA, Noble PW and Bourguignon LY: Signaling properties of hyaluronan receptors. J Biol Chem. 277:4589–4592. 2002. View Article : Google Scholar : PubMed/NCBI
10	Wang SJ and Bourguignon LY: Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. Am J Pathol. 178:956–963. 2011. View Article : Google Scholar : PubMed/NCBI
11	Kokko LL, Hurme S, Maula SM, Alanen K, Grénman R, Kinnunen I and Ventelä S: Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. Oral Oncol. 47:510–516. 2011. View Article : Google Scholar : PubMed/NCBI
12	Edge SB and Compton CC: The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI
13	Gillespie MB, Rubinchik S, Hoel B and Sutkowski N: Human papillomavirus and oropharyngeal cancer: What you need to know in 2009. Curr Treat Options Oncol. 10:296–307. 2009. View Article : Google Scholar : PubMed/NCBI
14	Hedberg JJ, Grafström RC, Vondracek M, Sarang Z, Wärngård L and Höög JO: Micro-array chip analysis of carbonyl-metabolising enzymes in normal, immortalised and malignant human oral keratinocytes. Cell Mol Life Sci. 58:1719–1726. 2001. View Article : Google Scholar : PubMed/NCBI
15	Kato H, Izumi K, Saito T, Ohnuki H, Terada M, Kawano Y, NozawaInoue K, Saito C and Maeda T: Distinct expression patterns and roles of aldehyde dehydrogenases in normal oral mucosa keratinocytes: Differential inhibitory effects of a pharmacological inhibitor and RNAi-mediated knockdown on cellular phenotype and epithelial morphology. Histochem Cell Biol. 139:847–862. 2013. View Article : Google Scholar : PubMed/NCBI
16	Sherman JA and Partridge M: Expression of retinoic acid receptors in normal, dysplastic and malignant oral epithelia. Br J Oral Maxillofac Surg. 35:260–266. 1997. View Article : Google Scholar : PubMed/NCBI
17	Makia NL, Amunom I, Falkner KC, Conklin DJ, Surapureddi S, Goldstein JA and Prough RA: Activator protein-1 regulation of murine aldehyde dehydrogenase 1a1. Mol Pharmacol. 82:601–613. 2012. View Article : Google Scholar : PubMed/NCBI
18	Maddox J, Shakya A, South S, Shelton D, Andersen JN, Chidester S, Kang J, Gligorich KM, Jones DA, Spangrude GJ, et al: Transcription factor Oct1 is a somatic and cancer stem cell determinant. PLoS Genet. 8:e10030482012. View Article : Google Scholar : PubMed/NCBI
19	Wang P and Jin T: Oct-1 functions as a sensor for metabolic and stress signals. Islets. 2:46–48. 2010. View Article : Google Scholar : PubMed/NCBI
20	Wong HK and Ziff EB: The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity. J Virol. 70:332–340. 1996.PubMed/NCBI
21	Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, et al: Towards a knowledge-based Human Protein Atlas. Nat Biotechnol. 28:1248–1250. 2010.Available from. http://www.proteinatlas.org View Article : Google Scholar : PubMed/NCBI
22	Qian X, Wagner S, Ma C, Coordes A, Gekeler J, Klussmann JP, Hummel M, Kaufmann AM and Albers AE: Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma. J Cancer Res Clin Oncol. 140:1151–1158. 2014. View Article : Google Scholar : PubMed/NCBI
23	Mack B and Gires O: CD44 s and CD44v6 expression in head and neck epithelia. PLoS One. 3:e33602008. View Article : Google Scholar : PubMed/NCBI
24	Sterz CM, Kulle C, Dakic B, Makarova G, Böttcher MC, Bette M, Werner JA and Mandic R: A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9. Oral Oncol. 46:116–122. 2010. View Article : Google Scholar : PubMed/NCBI
25	Richard V and Pillai MR: The stem cell code in oral epithelial tumorigenesis: ‘the cancer stem cell shift hypothesis’. Biochim Biophys Acta. 1806:146–162. 2010.PubMed/NCBI
26	Williams K, Motiani K, Giridhar PV and Kasper S: CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches. Exp Biol Med. 238:324–338. 2013. View Article : Google Scholar
27	Wang SJ and Bourguignon LY: Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg. 132:771–778. 2006. View Article : Google Scholar : PubMed/NCBI
28	Bourguignon LY, Gilad E, Brightman A, Diedrich F and Singleton P: Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem. 281:14026–14040. 2006. View Article : Google Scholar : PubMed/NCBI
29	Abhold EL, Kiang A, Rahimy E, Kuo SZ, WangRodriguez J, Lopez JP, Blair KJ, Yu MA, Haas M, Brumund KT, et al: EGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells. PLoS One. 7:e324592012. View Article : Google Scholar : PubMed/NCBI
30	Brabletz T, Jung A, Spaderna S, Hlubek F and Kirchner T: Opinion: Migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer. 5:744–749. 2005. View Article : Google Scholar : PubMed/NCBI
31	Brabletz T: EMT and MET in metastasis: Where are the cancer stem cells? Cancer Cell. 22:699–701. 2012. View Article : Google Scholar : PubMed/NCBI
32	Biddle A, Liang X, Gammon L, Fazil B, Harper LJ, Emich H, Costea DE and Mackenzie IC: Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res. 71:5317–5326. 2011. View Article : Google Scholar : PubMed/NCBI
33	Liu S, Clouthier SG and Wicha MS: Role of microRNAs in the regulation of breast cancer stem cells. J Mammary Gland Biol Neoplasia. 17:15–21. 2012. View Article : Google Scholar : PubMed/NCBI
34	French R and Clarkson R: The complex nature of breast cancer stem-like cells: Heterogeneity and plasticity. J Stem Cell Res Ther. S7:0092012.